U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-03-07 16:30 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, China, World News, Asia Pacific
--------------------------------------------------------------------
Snippet:
SHANGHAI, March 7, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently available only in China.
--------------------------------------------------------------------